Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213828 Adenovirus vaccine vector and methods of use
08/23/2012US20120213822 Chemo-immunotherapy method
08/23/2012US20120213821 Novel method for isolating endotoxins
08/23/2012US20120213820 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
08/23/2012US20120213819 Hemagglutinin polypeptides, and reagents and methods relating thereto
08/23/2012US20120213818 Combination therapy for immunostimulation
08/23/2012US20120213817 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
08/23/2012US20120213816 Mycoplasma hyopneumoniae bacterin vaccine
08/23/2012US20120213815 Vaccines and immunotherapeutics using codon-optimized il-15 and methods for using the same
08/23/2012US20120213814 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
08/23/2012US20120213813 Alphavirus replicon particles as immunological adjuvants
08/23/2012US20120213812 Immunostimulatory Oligonucleotides
08/23/2012US20120213811 Chimeric hiv fusion proteins as vaccines
08/23/2012US20120213810 Novel european prrsv strain
08/23/2012US20120213809 Vault complexes for cytokine delivery
08/23/2012US20120213808 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213805 Amatoxin-Armed Tartget-Binding Moieties for the Treatment of Cancer
08/23/2012US20120213804 Calicheamicin derivative-carrier conjugates
08/23/2012US20120213803 Methods for diagnosing and treating encephalitis or epilepsy
08/23/2012US20120213802 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
08/23/2012US20120213801 Phosphorylated Twist1 and cancer
08/23/2012US20120213800 Methods for treating and diagnosing disease
08/23/2012US20120213799 Compositions and methods for treating inflammatory disorders
08/23/2012US20120213798 Methods and uses for treating hepatic ischemia and reperfusion injury
08/23/2012US20120213797 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
08/23/2012US20120213796 Polyclonal antibody compositions
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213794 Ax213 and ax132 psck9 antagonists and variants
08/23/2012US20120213793 Cancer treatment
08/23/2012US20120213792 Human antibodies that bind human il-12 and methods for producing
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/23/2012US20120213789 New Molecular Target for Treatment of Cancer
08/23/2012US20120213788 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers
08/23/2012US20120213787 Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/23/2012US20120213786 Notch1 Binding Agents and Methods of Use Thereof
08/23/2012US20120213785 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
08/23/2012US20120213784 Method for the potentiation of opioid analgesics effects on pain
08/23/2012US20120213783 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
08/23/2012US20120213782 Bmp10 antibodies and related methods
08/23/2012US20120213781 Monovalent and Multivalent Multispecific Complexes and Uses Thereof
08/23/2012US20120213780 Efficient mucosal vaccination mediated by the neonatal Fc receptor
08/23/2012US20120213779 Fgf21 mutants and uses thereof
08/23/2012US20120213778 Method of detecting and treating tuberous sclerosis complex associated disorders
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213776 Antibodies to granulocyte-macrophage colony-stimulating factor
08/23/2012US20120213775 Treatment of renal diseases
08/23/2012US20120213774 Antibodies against human IL33R and uses thereof
08/23/2012US20120213773 Binding domain-immunoglobulin fusion proteins
08/23/2012US20120213772 Metabolic biomarkers of Crohn's Disease
08/23/2012US20120213771 Antibodies that bind human cd27 and uses thereof
08/23/2012US20120213770 Compostions and methods for identifying response targets and treating flavivirus infection responses
08/23/2012US20120213769 Methods of diagnosing amyotrophic lateral sclerosis (als)
08/23/2012US20120213768 Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213766 Anticancer Compounds from Vernonia Guineensis
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213705 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
08/23/2012US20120213699 Single chain fragment of monoclonal antibody 9b9 and uses thereof
08/23/2012DE102011004335A1 Verfahren zur Herstellung eines Vakzins A process for the preparation of a vaccine
08/23/2012CA2827443A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
08/23/2012CA2827337A1 Commercial scale process for production of prrsv
08/23/2012CA2827301A1 Compositions and methods for the therapy and diagnosis of influenza
08/23/2012CA2826920A1 Methods for enhancing immunogen specific immune responses by vectored vaccines
08/23/2012CA2826543A1 Treatment of fistulizing crohn's disease
08/23/2012CA2826341A1 Novel european prrsv strain
08/22/2012EP2489739A2 Materials and methods for respiratory disease control in canines
08/22/2012EP2489676A1 Method for treating liver inflammation, fibrosis and non-alcoholic steatohepatitis
08/22/2012EP2489675A1 ANTIBODY RECOGNIZING TURN STRUCTURE IN AMYLOID ß
08/22/2012EP2489673A2 Klebsiella antigens
08/22/2012EP2489368A1 Minor allergen control to increase safety of immunotherapy
08/22/2012EP2489367A1 Lyophilised antigen composition
08/22/2012EP2489364A1 Monomethylvaline compounds onjugated to antibodies
08/22/2012EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
08/22/2012EP2488640A1 Antiproliferative agent
08/22/2012EP2488634A1 Isolation of a virus related to canine parvovirus-2 from a raccoon
08/22/2012EP2488553A1 Cancer treatment
08/22/2012EP2488552A1 Use of il-17 receptor a antigen binding proteins
08/22/2012EP2488547A2 Staphylococcal antigens
08/22/2012EP2488204A1 Therapeutic combination and methods of treatment with a dll4 antagonist and an anti-hypertensive agent
08/22/2012EP2488202A1 Antibody therapeutics with local activity in the digestive tract
08/22/2012EP2488201A1 Il-1 binding proteins
08/22/2012EP2488200A1 April antagonists and methods of use
08/22/2012EP2488199A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
08/22/2012EP2488198A2 Treatment and diagnosis of inflammatory disorders
08/22/2012EP2488197A1 Th1/th2 polarizing vaccines
08/22/2012EP2488196A1 Composition for treatment of multiple sclerosis
08/22/2012EP2488186A1 Anti-neoplastic uses of artemin antagonists
08/22/2012EP2488185A1 Infectious clones of torque teno virus
08/22/2012EP2460878A9 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof
08/22/2012EP2011508B1 Use of trap protein per se as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection
08/22/2012EP1998805B1 Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
08/22/2012EP1899377B1 Humanised antibodies specific for nogo-a and phrarmaceutical uses thereof
08/22/2012EP1876240B1 Anti-human platelet membrane glycoprotein vi monoclonal antibody
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1823